Data / Form D filings / Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc.: Form D filing
Perceive Biotherapeutics, Inc., a biotechnology company in South San Francisco, CA, filed a Form D with the SEC in 2023. The latest, on January 13, 2023, reports $40 million sold of a $78 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6000 SHORELINE DRIVE, SUITE 206, ATTN: CEO, South San Francisco, CA, 94080
- Phone
- (707) 477-8172
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1962036
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 13, 2023 | New notice | $77,999,974 | $39,999,986 | $37,999,988 | 6 | Dec 29, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Watson Angela Debi | Director | |
| Anne Angela Rubin | Executive Officer, Director | |
| Kirsten Angela Macfarlane | Executive Officer, Director, Promoter | |
| Cameron Angela Wheeler | Director | |
| Randall Angela Olson | Director | |
| Robert Angela Jackson | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 9, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Perceive Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.